Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...
May 16, 2025 (Gmt+09:00)
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...
Feb 12, 2025 (Gmt+09:00)
LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...
Feb 09, 2025 (Gmt+09:00)
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
Feb 05, 2025 (Gmt+09:00)
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Dec 11, 2024 (Gmt+09:00)
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
South Korea’s LG Energy Solution Ltd. said on Monday it has signed an initial agreement to supply cylindrical battery cells to Bear Robotics I...
Nov 18, 2024 (Gmt+09:00)
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
Nov 05, 2024 (Gmt+09:00)
South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...
Oct 29, 2024 (Gmt+09:00)
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
Oct 25, 2024 (Gmt+09:00)
South Korea's Mirae Asset Securities Co. said on Tuesday that its defined contribution (DC) retirement pension and individual retirement pension (IR...
Oct 22, 2024 (Gmt+09:00)
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Oct 11, 2024 (Gmt+09:00)
LG Energy Solution Ltd. has vowed to more than double its sales in five years to 67 trillion won ($50 billion) by diversifying its battery products ...
Oct 07, 2024 (Gmt+09:00)
South Korea's Hanwha Galleria Corp. said on Monday its acquisition of domestic beverage manufacturer Pure Plus.Pure Plus has focused on non-alcoholi...
Sep 24, 2024 (Gmt+09:00)
South Korea's Osstem Implant Co., the world’s fourth-largest dental implant maker, will enhance its software system of digital dentistry. ...
Sep 24, 2024 (Gmt+09:00)
South Korea's Taihan Cable & Solution Co. said on Thursday that it was selected as the cable supplier for a 320kV voltage-type high-voltage dire...
Sep 19, 2024 (Gmt+09:00)
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...
Aug 30, 2024 (Gmt+09:00)